156 related articles for article (PubMed ID: 33083892)
21. Screening Women Aged 50-59 for CRC Using Fecal Occult Blood Test Produces Outcomes Similar to Men Undergoing Screening Colonoscopy.
Mooers HM; Holub JL; Lieberman DA
Dig Dis Sci; 2018 Oct; 63(10):2780-2785. PubMed ID: 29948570
[TBL] [Abstract][Full Text] [Related]
22. Sex is a stronger predictor of colorectal adenoma and advanced adenoma than fecal occult blood test.
Ferlitsch M; Heinze G; Salzl P; Britto-Arias M; Waldmann E; Reinhart K; Bannert C; Fasching E; Knoflach P; Weiss W; Trauner M; Ferlitsch A
Med Oncol; 2014 Sep; 31(9):151. PubMed ID: 25115743
[TBL] [Abstract][Full Text] [Related]
23. Ontario's ColonCancerCheck: results from canada's first province-wide colorectal cancer screening program.
Rabeneck L; Tinmouth JM; Paszat LF; Baxter NN; Marrett LD; Ruco A; Lewis N; Gao J
Cancer Epidemiol Biomarkers Prev; 2014 Mar; 23(3):508-15. PubMed ID: 24443406
[TBL] [Abstract][Full Text] [Related]
24. Ethnic differences and predictors of colonoscopy, prostate-specific antigen, and mammography screening participation in the multiethnic cohort.
Harmon BE; Little MA; Woekel ED; Ettienne R; Long CR; Wilkens LR; Le Marchand L; Henderson BE; Kolonel LN; Maskarinec G
Cancer Epidemiol; 2014 Apr; 38(2):162-7. PubMed ID: 24667037
[TBL] [Abstract][Full Text] [Related]
25. What influences family physicians' cancer screening decisions when practice guidelines are unclear or conflicting?
Tudiver F; Guibert R; Haggerty J; Ciampi A; Medved W; Brown JB; Herbert C; Katz A; Ritvo P; Grant B; Goel V; Smith P; O'Beirne M; Williams JI; Moliner P
J Fam Pract; 2002 Sep; 51(9):760. PubMed ID: 12366894
[TBL] [Abstract][Full Text] [Related]
26. Influence of family history and preventive health behaviors on colorectal cancer screening in African Americans.
Griffith KA; McGuire DB; Royak-Schaler R; Plowden KO; Steinberger EK
Cancer; 2008 Jul; 113(2):276-85. PubMed ID: 18543276
[TBL] [Abstract][Full Text] [Related]
27. The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening.
Almog R; Ezra G; Lavi I; Rennert G; Hagoel L
Eur J Cancer Prev; 2008 Oct; 17(5):430-7. PubMed ID: 18714185
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness of Screening Using Fecal Occult Blood Testing and Colonoscopy on the Risk of Colorectal Cancer: The Japan Public Health Center-based Prospective Study.
Tanaka K; Sobue T; Zha L; Kitamura T; Sawada N; Iwasaki M; Inoue M; Yamaji T; Tsugane S
J Epidemiol; 2023 Feb; 33(2):91-100. PubMed ID: 34053963
[TBL] [Abstract][Full Text] [Related]
29. Association of Race and Socioeconomic Status With Colorectal Cancer Screening, Colorectal Cancer Risk, and Mortality in Southern US Adults.
Warren Andersen S; Blot WJ; Lipworth L; Steinwandel M; Murff HJ; Zheng W
JAMA Netw Open; 2019 Dec; 2(12):e1917995. PubMed ID: 31860105
[TBL] [Abstract][Full Text] [Related]
30. Breast, cervical, and colorectal carcinoma screening in a demographically defined region of the southern U.S.
Coughlin SS; Thompson TD; Seeff L; Richards T; Stallings F
Cancer; 2002 Nov; 95(10):2211-22. PubMed ID: 12412176
[TBL] [Abstract][Full Text] [Related]
31. The cumulative risk of false-positive fecal occult blood test after 10 years of colorectal cancer screening.
Hubbard RA; Johnson E; Hsia R; Rutter CM
Cancer Epidemiol Biomarkers Prev; 2013 Sep; 22(9):1612-9. PubMed ID: 23868091
[TBL] [Abstract][Full Text] [Related]
32. Determinants of participation in prostate cancer screening: a simple analytical framework to account for healthy-user bias.
Tabuchi T; Nakayama T; Fukushima W; Matsunaga I; Ohfuji S; Kondo K; Kawano E; Fukuhara H; Ito Y; Oshima A
Cancer Sci; 2015 Jan; 106(1):108-14. PubMed ID: 25456306
[TBL] [Abstract][Full Text] [Related]
33. Estimated Lifetime Gained With Cancer Screening Tests: A Meta-Analysis of Randomized Clinical Trials.
Bretthauer M; Wieszczy P; Løberg M; Kaminski MF; Werner TF; Helsingen LM; Mori Y; Holme Ø; Adami HO; Kalager M
JAMA Intern Med; 2023 Nov; 183(11):1196-1203. PubMed ID: 37639247
[TBL] [Abstract][Full Text] [Related]
34. Screening men for prostate cancer and colorectal cancer: is practice evidence-based?
Chun FK; Suardi N; Perrotte P; Lebeau T; Guay JP; Benayoun S; Ramirez A; Bénard F; McCormack M; Valiquette L; Karakiewicz P
Can J Urol; 2007 Dec; 14(6):3727-33. PubMed ID: 18163923
[TBL] [Abstract][Full Text] [Related]
35. "Shared decision-making" for prostate cancer screening: Is it a marker of quality preventative healthcare?
Golijanin B; Bhatt V; Homer A; Malshy K; Ochsner A; Wales R; Khaleel S; Mega A; Pareek G; Hyams E
Cancer Epidemiol; 2024 Feb; 88():102492. PubMed ID: 38056246
[TBL] [Abstract][Full Text] [Related]
36. [Examples of screening investigations].
Eickhoff A; Hahn A; Riemann JF
Internist (Berl); 2008 Jun; 49(6):660, 662-4, 666-8, 670-2. PubMed ID: 18461294
[TBL] [Abstract][Full Text] [Related]
37. Behavioral associations between prostate and colon cancer screening.
Carlos RC; Underwood W; Fendrick AM; Bernstein SJ
J Am Coll Surg; 2005 Feb; 200(2):216-23. PubMed ID: 15664097
[TBL] [Abstract][Full Text] [Related]
38. Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study.
Fraser CG; Matthew CM; Mowat NA; Wilson JA; Carey FA; Steele RJ
Lancet Oncol; 2006 Feb; 7(2):127-31. PubMed ID: 16455476
[TBL] [Abstract][Full Text] [Related]
39. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
40. Results of National Colorectal Cancer Screening Program in Croatia (2007-2011).
Katičić M; Antoljak N; Kujundžić M; Stamenić V; Skoko Poljak D; Kramarić D; Stimac D; Strnad Pešikan M; Samija M; Ebling Z
World J Gastroenterol; 2012 Aug; 18(32):4300-7. PubMed ID: 22969192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
